Quick Answer
Sight Sciences, Inc. reported Cash and Equivalents of $91.97 million for fiscal year 2025.
Sight Sciences, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $91.97M | -23.6% |
| 2024 | $120.36M | -12.9% |
| 2023 | $138.13M | -25.3% |
| 2022 | $185.00M | -29.0% |
| 2021 | $260.69M | +323.8% |
| 2020 | $61.51M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $92.37M | -22.1% | -9.0% |
| June 30, 2025 | $101.50M | -14.1% | -6.7% |
| March 31, 2025 | $108.77M | -14.5% | -9.6% |
| December 31, 2024 | $120.36M | -12.9% | +1.5% |
| September 30, 2024 | $118.56M | -17.9% | +0.3% |
| June 30, 2024 | $118.18M | -23.5% | -7.2% |
| March 31, 2024 | $127.28M | -23.9% | -7.9% |
| December 31, 2023 | $138.13M | -25.3% | -4.4% |
- Sight Sciences, Inc. showed a decrease of -23.6% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2020–2025 period, Sight Sciences, Inc.’s cash and equivalents has grown by 49.5% (from $61.51 million to $91.97 million).
- The most recent figure is from Sight Sciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 4, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: